Stocks News

LAST PRICE
215.2000
TODAY'S CHANGE (%)
Trending Up6.3000 (3.0158%)

Bid / Lots
214.9900/ 4
Ask / Lots
215.2700/ 4
Open / Previous Close
208.9900 / 208.9000
Day Range
Low 208.5443
High 218.8600
52 Week Range
Low 189.4400
High 319.7600
Volume
1,436,066
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Biogen Is Maintained at Outperform by Oppenheimer, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 12:59 ET (16:59 GMT)
- DJ Biogen on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: BIIB
  
  Biogen Inc. (BIIB) is currently at $218.61, up $9.71 or 4.65%
  
  --Would be highest close since March 21, 2024, when it closed at $220.75
  
  --On pace for largest percent increase since Nov. 30, 2022, when it rose 4.72%
Apr 26, 2024
- Guggenheim Adjusts Price Target on Biogen to $255 From $275, from 11:27AM ET on Friday Apr 26, 2024 by MT Newswires
  11:27AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: BIIB
  11:27 AM EDT, 04/26/2024 (MT Newswires) -- Biogen (BIIB) has an average outperform rating and a price target range of $200 to $350, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major b...
Apr 25, 2024
- Biogen Receives Positive CHMP Opinion for TOFIDENCE(TM) (tocilizumab), a Biosimilar Referencing ROACTEMRA(R), from 4:05PM ET on Thursday Apr 25, 2024 by Dow Jones
  4:05PM ET on Thursday Apr 25, 2024 by Dow Jones
  Companies Mentioned: BIIB
  -- CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE(TM) to the reference product ROACTEMRA(R)
  CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen https://www.globenewswire.com/Tracker?data=JltSjy9lWtnRNP_h46Do6CQXMKhX9f9BXMsNLgqhTdWgQfB8rptF2yBxnQhitNgFarf6yZ-9wh0a7LjOM-p-vQ== Inc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE(TM) (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA(R)1 . The intravenous formulation of TOFIDENCE has been recommended for approval for the treatment of moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19.
- DJ Biogen Is Maintained at Equal-Weight by Barclays, from 2:12PM ET on Thursday Apr 25, 2024 by Dow Jones
  2:12PM ET on Thursday Apr 25, 2024 by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 25, 2024 14:12 ET (18:12 GMT)

Apr 26, 2024
- --UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating, from 10:54AM ET on Friday Apr 26, 2024 by MT Newswires
  10:54AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: ICLR
Apr 25, 2024
- Sector Update: Health Care Stocks Drop in Afternoon Trading, from 1:51PM ET on Thursday Apr 25, 2024 by MT Newswires
  1:51PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: GSK, PFE, BNTX, AZN, BMY
- Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines, from 12:55PM ET on Thursday Apr 25, 2024 by MT Newswires
  12:55PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: GSK, PFE, BNTX
- GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines, from 11:27AM ET on Thursday Apr 25, 2024 by MT Newswires
  11:27AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: GSK, PFE, BNTX
Apr 24, 2024
- ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed, from 4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ICLR
- -- Earnings Flash (ICLR) ICON Reports Q1 EPS $3.47, vs. Street Est of $3.41, from 4:16PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:16PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ICLR
- -- Earnings Flash (ICLR) ICON Reports Q1 Revenue $2.09B, vs. Street Est of $2.088B, from 4:15PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:15PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ICLR
- ICON Reports First Quarter 2024 Results, from 4:15PM ET on Wednesday Apr 24, 2024 by Business Wire
  4:15PM ET on Wednesday Apr 24, 2024 by Business Wire
  Companies Mentioned: ICLR
- Sector Update: Health Care Stocks Slipping Late Afternoon, from 3:58PM ET on Wednesday Apr 24, 2024 by MT Newswires
  3:58PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: HUM, NVO, MRNA, BIIB
- Moderna to Collaborate With OpenAI to Launch New Generation of Medicines, from 11:36AM ET on Wednesday Apr 24, 2024 by MT Newswires
  11:36AM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: MSFT, MRNA

Biogen Inc
NASDAQ:BIIBUnited States

Search Criteria

Today

DJ Biogen Is Maintained at Outperform by Oppenheimer, from 1 hour ago by Dow Jones

DJ Biogen on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 3 hours ago by Dow Jones

Apr 26, 2024

Guggenheim Adjusts Price Target on Biogen to $255 From $275, from 11:27AM ET on Friday Apr 26, 2024 by MT Newswires

Apr 25, 2024

Biogen Receives Positive CHMP Opinion for TOFIDENCE(TM) (tocilizumab), a Biosimilar Referencing ROACTEMRA(R), from 4:05PM ET on Thursday Apr 25, 2024 by Dow Jones

DJ Biogen Is Maintained at Equal-Weight by Barclays, from 2:12PM ET on Thursday Apr 25, 2024 by Dow Jones

Peers Headlines

Apr 26, 2024

--UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating, from 10:54AM ET on Friday Apr 26, 2024 by MT Newswires

Apr 25, 2024

Sector Update: Health Care Stocks Drop in Afternoon Trading, from 1:51PM ET on Thursday Apr 25, 2024 by MT Newswires

Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines, from 12:55PM ET on Thursday Apr 25, 2024 by MT Newswires

GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines, from 11:27AM ET on Thursday Apr 25, 2024 by MT Newswires

Apr 24, 2024

ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed, from 4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires

-- Earnings Flash (ICLR) ICON Reports Q1 EPS $3.47, vs. Street Est of $3.41, from 4:16PM ET on Wednesday Apr 24, 2024 by MT Newswires

-- Earnings Flash (ICLR) ICON Reports Q1 Revenue $2.09B, vs. Street Est of $2.088B, from 4:15PM ET on Wednesday Apr 24, 2024 by MT Newswires

ICON Reports First Quarter 2024 Results, from 4:15PM ET on Wednesday Apr 24, 2024 by Business Wire

Sector Update: Health Care Stocks Slipping Late Afternoon, from 3:58PM ET on Wednesday Apr 24, 2024 by MT Newswires

Moderna to Collaborate With OpenAI to Launch New Generation of Medicines, from 11:36AM ET on Wednesday Apr 24, 2024 by MT Newswires